Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation
CardiologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Circulation
- Publicado em
- 24 jan 2024
- Citações
- 33
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation
Siddharth M Patel, Eugene Braunwald, Jan Steffel, Giuseppe Boriani, Michael G Palazzolo, Elliott M Antman, Erin A Bohula, Anthony P Carnicelli, Stuart J Connolly, John W. Eikelboom et al.
Descritores MeSH
- Atrial Fibrillation
- Stroke
- Body Weight
- Hemorrhage
- Administration, Oral
- Warfarin
- Body Mass Index
- Randomized Controlled Trials as Topic
- Treatment Outcome
- Humans